DNA methylation screening of primary prostate tumors identifies SRD5A2 and CYP11A1 as candidate markers for assessing risk of biochemical recurrence

Effect of Finasteride on Serum Androstenedione and Risk of Prostate Cancer Within the Prostate Cancer Prevention Trial: Differential Effect on High- and Low-grade Disease

(2015) Ashraful Hoque et al.   UROLOGY

Genome-wide DNA methylation analysis reveals estrogen-mediated epigenetic repression of metallothionein-1 gene cluster in breast cancer

(2015) Rohit R Jadhav et al.   Clinical Epigenetics

Gene Microarray Assessment of Multiple Genes and Signal Pathways Involved in Androgen-dependent Prostate Cancer Becoming Androgen Independent

(2015) Jun-Bao Liu et al.   Asian Pacific Journal of Cancer Prevention

Evaluation of protein biomarkers of prostate cancer aggressiveness

(2014) Anthony E Rizzardi et al.   BMC CANCER

Prognostic DNA Methylation Markers for Prostate Cancer

(2014) Siri Strand et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Correlation between Plasma DNA and Tumor Status in an Animal Model

(2014) Naoko Sueoka-Aragane et al.   PLoS One

Finasteride treatment alters tissue specific androgen receptor expression in prostate tissues

(2014) Tyler M. Bauman et al.   PROSTATE

Active Surveillance for Prostate Cancer: Overview and Update

(2013) Laurence Klotz   CURRENT TREATMENT OPTIONS IN ONCOLOGY

Steroidogenic Factor 1 Promotes Aggressive Growth of Castration-Resistant Prostate Cancer Cells by Stimulating Steroid Synthesis and Cell Proliferation

(2013) Samantha R. Lewis et al.   ENDOCRINOLOGY

Survival Following Biochemical Recurrence After Radical Prostatectomy and Adjuvant Radiotherapy in Patients With Prostate Cancer: The Impact of Competing Causes of Mortality and Patient Stratification

(2013) Firas Abdollah et al.   EUROPEAN UROLOGY

Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA

(2013) Muhammed Murtaza et al.   NATURE

Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy

(2013) Nicholas Erho et al.   PLoS One

Characterization of Prostate Cancer Bone Metastases According to Expression Levels of Steroidogenic Enzymes and Androgen Receptor Splice Variants

(2013) Emma Jernberg et al.   PLoS One

Prostate cancer cells differ in testosterone accumulation, dihydrotestosterone conversion, and androgen receptor signaling response to steroid 5α-reductase inhibitors

(2013) Yue Wu et al.   PROSTATE

DNA Methylation Alterations Exhibit Intraindividual Stability and Interindividual Heterogeneity in Prostate Cancer Metastases

(2013) M. J. Aryee et al.   Science Translational Medicine

Distinct Patterns of Dysregulated Expression of Enzymes Involved in Androgen Synthesis and Metabolism in Metastatic Prostate Cancer Tumors

(2012) N. Mitsiades et al.   CANCER RESEARCH

Global Methylation Profiling for Risk Prediction of Prostate Cancer

(2012) S. Mahapatra et al.   CLINICAL CANCER RESEARCH

Quantitative DNA methylation analysis of genes coding for kallikrein-related peptidases 6 and 10 as biomarkers for prostate cancer

(2012) Ekaterina Olkhov-Mitsel et al.   Epigenetics

Characterization of cell-free circulating DNA in plasma in patients with prostate cancer

(2012) Pâmela Oliveira Delgado et al.   TUMOR BIOLOGY

Association of tissue promoter methylation levels of APC, TGFβ2, HOXD3 and RASSF1A with prostate cancer progression

(2011) Liyang Liu et al.   INTERNATIONAL JOURNAL OF CANCER

Identification of genetic elements that autonomously determine DNA methylation states

(2011) Florian Lienert et al.   NATURE GENETICS

Dihydrotestosterone synthesis bypasses testosterone to drive castration-resistant prostate cancer

(2011) K.-H. Chang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Finasteride upregulates expression of androgen receptor in hyperplastic prostate and LNCaP cells: Implications for chemoprevention of prostate cancer

(2011) Ju-Ton Hsieh et al.   PROSTATE

Multicenter Clinical Validation of PITX2 Methylation as a Prostate Specific Antigen Recurrence Predictor in Patients With Post-Radical Prostatectomy Prostate Cancer

(2010) Lionel L. Bañez et al.   JOURNAL OF UROLOGY

DNA methylation of HOXD3 as a marker of prostate cancer progression

(2010) Ken J Kron et al.   LABORATORY INVESTIGATION

DNA Methylation of the PITX2 Gene Promoter Region is a Strong Independent Prognostic Marker of Biochemical Recurrence in Patients With Prostate Cancer After Radical Prostatectomy

(2009) Gunter Weiss et al.   JOURNAL OF UROLOGY

Androgen biosynthetic pathways in the human prostate

(2008) Van Luu-The et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Maintenance of Intratumoral Androgens in Metastatic Prostate Cancer: A Mechanism for Castration-Resistant Tumor Growth

(2008) R. B. Montgomery et al.   CANCER RESEARCH